Over the past decade, molecular diagnostics have transformed how we assess cancer risks, help avoid unnecessary surgeries, and make personalized treatment decisions. In this episode, we’ll discuss the evolution of the molecular testing, review commonly used platforms, and explore how to apply the results effectively in clinical practice.
From Clinical Thyroidology® for the Public: Some patients with Graves’ disease develop thyroid eye disease,…
From Clinical Thyroidology® for the Public: GLP1 receptor agonists (GLP1-RAs) are popular medications that are…
From Clinical Thyroidology® for the Public: TSH and FT4 tests are commonly ordered to evaluate…
The Thyroid Stimulating Podcast was created in partnership with the American Thyroid Association® and Medscape…
From Clinical Thyroidology® for the Public: In many cases, the dose of thyroid hormone required…
The Thyroid Stimulating Podcast was created in partnership with the American Thyroid Association® and Medscape…
As 2024 comes to a close, we would like to take the opportunity to share…
From Clinical Thyroidology® for the Public: Proton-pump inhibitors (PPIs) lower the amount of acid the…
FOR IMMEDIATE RELEASE December 6, 2024 Contact: Hayley Gray-Hoehn, hayley.gray-hoehn@mail.house.gov Washington, D.C. – Wednesday, U.S….
AMERICAN THYROID ASSOCIATION® , ATA® , THYROID® , CLINICAL THYROIDOLOGY® , and the distinctive circular logo are registered in the U.S. Patent and Trademark Office as trademarks of the American Thyroid Association® , Inc.© 2025 American Thyroid Association.
